Capranico G, Jaxel C, Roberge M, Kohn K W, Pommier Y
Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Nucleic Acids Res. 1990 Aug 11;18(15):4553-9. doi: 10.1093/nar/18.15.4553.
We have assessed the ability of nucleosomes to influence the formation of mammalian topoisomerase II-DNA complexes by mapping the sites of cleavage induced by four unrelated topoisomerase II inhibitors in naked versus nucleosome-reconstituted SV40 DNA. DNA fragments were reconstituted with histone octamers from HeLa cells by the histone exchange method. Nucleosome positions were determined by comparing micrococcal nuclease cleavage patterns of nucleosome-reconstituted and naked DNA. Three types of DNA regions were defined: 1) regions with fixed nucleosome positioning; 2) regions lacking regular nucleosome phasing; and 3) a region around the replication origin (from position 5100 to 600) with no detectable nucleosomes. Topoisomerase II cleavage sites were suppressed in nucleosomes and persisted or were enhanced in linker DNA and in the nucleosome-free region around the replication origin. Incubation of reconstituted chromatin with topoisomerase II protected nucleosome-free regions from micrococcal nuclease cleavage without changing the overall micrococcal nuclease cleavage pattern. Thus, the present results indicate that topoisomerase II binds preferentially to nucleosome-free DNA and that the presence of nucleosomes at preferred DNA sequences influences drug-induced DNA breaks by topoisomerase II inhibitors.
我们通过绘制四种不相关的拓扑异构酶II抑制剂在裸露的与核小体重构的SV40 DNA中诱导的切割位点,评估了核小体影响哺乳动物拓扑异构酶II-DNA复合物形成的能力。通过组蛋白交换法,用来自HeLa细胞的组蛋白八聚体重构DNA片段。通过比较核小体重构DNA和裸露DNA的微球菌核酸酶切割模式来确定核小体位置。定义了三种类型的DNA区域:1)具有固定核小体定位的区域;2)缺乏规则核小体相位的区域;3)复制起点周围(从位置5100到600)没有可检测到核小体的区域。拓扑异构酶II切割位点在核小体中受到抑制,在连接DNA和复制起点周围的无核小体区域持续存在或增强。用拓扑异构酶II孵育重构染色质可保护无核小体区域免受微球菌核酸酶切割,而不改变整体微球菌核酸酶切割模式。因此,目前的结果表明拓扑异构酶II优先结合无核小体的DNA,并且在优选DNA序列处核小体的存在会影响拓扑异构酶II抑制剂诱导的DNA断裂。